Skip to main content
. 2017 Mar 14;11:759–769. doi: 10.2147/DDDT.S121122

Figure 1.

Figure 1

The structure of the newly synthesized anticancer agent (compound 1).

Note: Compound 1, 3-amino-5-oxo-N-naphthyl-5,6,7,8-tetrahydrothieno[2,3-b] quinoline-2-carboxamide.